Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
Optically impure tamsulosin including racemic tamsulosin can be resolved into optically pure (R)- or (S)-tamsulosin by the use of diastereomeric sulfonate salts of tamsulosin in a fractional crystallization technique. Racemic tamsulosin free base is a useful starting material for the resolution process and a method of obtaining the same in solid form, including two crystalline polymorphic forms, is also provided.
1. Racemic tamsulosin free base in solid state.
2. The racemic tamsulosin according to claim 1 , wherein said solid state is a precipitate.
3. The racemic tamsulosin according to claim 1 , wherein said solid state is a crystalline form.
4. The racemic tamsulosin according to claim 1 , wherein said racemic tamsulosin is a white or almost white microcrystalline substance.
5. The racemic tamsulosin according to claim 1 , wherein said racemic tamsulosin is isolated racemic tamsulosin.
6. The racemic tamsulosin according to claim 5 , wherein said racemic tamsulosin is at least 80% pure.
7. The racemic tamsulosin according to claim 6 , wherein said racemic tamsulosin is at least 90% pure.
8. The racemic tamsulosin according to claim 7 , wherein said racemic tamsulosin is at least 95% pure.
9. The racemic tamsulosin according to claim 1 , which is polymorphic Form 1 .
10. The racemic tamsulosin according to claim 1 , which is polymorphic Form 2 .
11. A process for producing racemic tamsulosin free base in solid state, which comprises precipitating racemic tamsulosin free base from a solution containing racemic tamsulosin free base in a solvent, wherein said solvent comprises at least one of water or a lower alcohol.
12. The process according to claim 11 , wherein said solvent comprises water.
13. The process according to claim 11 , wherein said solvent is water.
14. The process according to claim 13 , which further comprises dissolving a racemic tamsulsoin free base residue in water to form said solution of racemic tamsulosin free base.
15. The process according to claim 11 , wherein said solvent is a mixture of a lower alcohol and water.
16. The process according to claim 15 , wherein said solvent is a methanol and water mixture.
17. The process according to claim 11 , wherein said solvent comprises a lower alcohol.
18. The process according to claim 17 , wherein said solvent is methanol.
19. The process according to claim 17 , wherein said solvent is an ethyl acetate and methanol mixture.
20. The process according to claim 19 , which further comprises dissolving a racemic tamsulsoin free base residue in an ethyl acetate and methanol mixture to form said solution of racemic tamsulosin free base.
21. The process according to claim 11 , wherein said precipitation is carried out by adding water to the solution, reducing the temperature of the solution, or both.
22. The process according to claim 11 , which futher comprises isolating said precipitated racemic tamsulosin free base.
23. The process according to claim 22 , wherein said isolated racemic tamsulosin free base has a purity of at least 95%.
24. The process according to claim 11 , which further comprises treating an acid addition salt of racemic tamsulosin with a base in a solvent that comprises at least one of water or a lower alcohol to form said solution of racemic tamsulosin.
25. The process according to claim 24 , wherein said treating is carried out in methanol or a water and methanol mixture.
26. The process according to claim 24 , which further comprises adding water concurrently with said treating with base.
27. The process according to claim 24 , wherein said acid addition salt of tamsulosin is tamsulosin hydrochloride.
28. A process for isolation of tamsulosin free base, which comprises treating an acid addition salt of tamsulosin in a solvent with a base and precipitating tamsulosin free base from said solvent, wherein said solvent comprises water, a lower alcohol or both.
29. The process according to claim 28 , wherein said solvent is a water and methanol mixture.
30. The process according to claim 28 , wherein said acid addition salt of tamsulosin is a tamsulosin camphor-10-sulfonate salt.
31. The process according to claim 28 , wherein said acid addition salt of tamsulosin is tamsulosin hydrochloride.
32. The process according to claim 28 , wherein said tamsulosin free base is essentially racemic.